Marfan syndrome and adolescent idiopathic scoliosis patients have similar 90-day postoperative outcomes and 5-year reoperation rates after spinal deformity surgery

• Published in: Spine deformity Vol. 10; no. 5; pp. 1169 - 1174
• Main Authors: Joo, Peter Y., Caruana, Dennis L., Gouzoulis, Michael J., Moore, Harold G., Zhu, Justin R., Ameri, Bijan, Grauer, Jonathan N.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.09.2022
• Subjects: Case Series; Medicine; Medicine & Public Health; Orthopedics; Deformity correction; Syndromic scoliosis; Adolescent idiopathic scoliosis; Spinal deformity; Marfan syndrome; Posterior spinal fusion
• ISSN: 2212-134X; 2212-1358
• DOI: 10.1007/s43390-022-00501-z

Purpose Outcomes after spinal deformity surgery in patients with Marfan syndrome (MFS) are poorly characterized given the rarity of the condition. Updated analyses from nationally representative samples, and comparison to outcomes after more commonly performed procedures for conditions such as adolescent idiopathic scoliosis (AIS) could help define the relative risks. Methods Using the 2010–2020 PearlDiver administrative databases, patients who underwent posterior spinal fusion for > 7 segments were extracted. MFS patients were matched 1:4 to AIS patients based on age, sex, and Elixhauer comorbidity index (ECI). Ninety-day outcomes and 5-year reoperation rates were compared. Significance was set at p  < 0.05. Results In total, 206 MFS patients were matched to 825 AIS patients. After adjusting for age, sex, and ECI, multivariate odds ratios (OR) for 90-day any, serious, and minor adverse events, as well as readmissions, were not significantly different for those with MFS compared to those with AIS ( p  > 0.05 for each). Five-year reoperation rates were also not significantly different (13.1% for the MFS cohort and 13.0% for the AIS cohort (no difference by log-rank, p  = 0.9). Conclusion While deformity surgery is much less commonly performed for MFS than AIS, it is not uncommonly considered for patients with this condition. Despite some known technical challenges for MFS deformity surgery, the current study leveraged a large, national database to find that 90-day adverse events and 5-year reoperations were not different for matched MFS and AIS patients undergoing deformity surgery. For select patients, these findings should be useful for surgical planning and patient counseling.